U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 344

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr3:45921375-50787353
GRCh38:
Chr3:45879883-50749922
ALS2CL, AMIGO3, AMT, APEH, ARIH2, ARIH2OS, ATRIP, ATRIP-TREX1, BSN, BSN-DT, C3orf18, C3orf62, C3orf84, CACNA2D2, CAMKV, CAMP, CCDC12, CCDC51, CCDC71, CCR1, CCR2, CCR3, CCR5, CCR5AS, CCR9, CCRL2, CDC25A, CDHR4, CELSR3, CISH, COL7A1, CRIPTO, CSPG5, CXCR6, CYB561D2, DAG1, DALRD3, DHX30, DOCK3, ELP6, FAM240A, FBXW12, FYCO1, GMPPB, GNAI2, GNAT1, GPX1, HEMK1, HYAL1, HYAL2, HYAL3, IFRD2, IHO1, IMPDH2, INKA1, IP6K1, IP6K2, KIF9, KIF9-AS1, KLHDC8B, KLHL18, LAMB2, LINC02009, LINC02019, LINC02585, LOC101928965, LOC110121200, LOC111591507, LOC112935943, LOC112935944, LOC112935945, LOC112935946, LOC115995510, LOC119086083, LOC121009664, LOC121009665, LOC121009666, LOC121009667, LOC121009668, LOC121009669, LOC121009670, LOC121009671, LOC121725144, LOC122889078, LOC122889079, LOC122889080, LOC122889081, LOC122889082, LOC122889083, LOC122889084, LOC122889085, LOC122889086, LOC122889087, LOC122889088, LOC126806671, LOC126806672, LOC126806673, LOC126806674, LOC126806675, LOC126806676, LOC127898564, LRRC2, LRRC2-AS1, LSMEM2, LTF, LZTFL1, MAP4, MAPKAPK3, MIR1226, MIR191, MIR2115, MIR425, MIR4271, MIR4443, MIR4787, MIR4793, MIR5193, MIR566, MIR5787, MIR6823, MIR6824, MIR6872, MIR6890, MIR711, MON1A, MST1, MST1R, MYL3, NAA80, NBEAL2, NCKIPSD, NDUFAF3, NICN1, NME6, NPRL2, P4HTM, PFKFB4, PLXNB1, PRKAR2A, PRKAR2A-AS1, PRSS50, PTH1R, PTPN23, QARS1, QRICH1, RASSF1, RASSF1-AS1, RBM5, RBM5-AS1, RBM6, RHOA, RNF123, RTP3, SCAP, SEMA3B, SEMA3B-AS1, SEMA3F, SEMA3F-AS1, SETD2, SHISA5, SLC25A20, SLC26A6, SLC38A3, SMARCC1, SNORA94, SNORD13J, SNORD146, SPINK8, TCTA, TMA7, TMEM115, TMEM89, TMIE, TRAIP, TREX1, TUSC2, UBA7, UCN2, UQCRC1, USP19, USP4, WDR6, XCR1, ZMYND10, ZNF589
See casesPathogenic
(Sep 23, 2013)
no assertion criteria provided
2.
GRCh37:
Chr3:46768104-47009805
GRCh38:
Chr3:46726614-46968315
CCDC12, LOC112935943, LOC121009666, LOC122889081, MYL3, PTH1RSee casesPathogenic
(Aug 13, 2012)
no assertion criteria provided
3.
GRCh37:
Chr3:46899400
GRCh38:
Chr3:46857910
MYL3Hypertrophic cardiomyopathyUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
4.
GRCh37:
Chr3:46899465
GRCh38:
Chr3:46857975
MYL3Hypertrophic cardiomyopathy 8Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
5.
GRCh37:
Chr3:46899493
GRCh38:
Chr3:46858003
MYL3Hypertrophic cardiomyopathy 8Uncertain significance
(Aug 9, 2021)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr3:46899516
GRCh38:
Chr3:46858026
MYL3Hypertrophic cardiomyopathy 8, not providedBenign
(Jun 26, 2018)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr3:46899578
GRCh38:
Chr3:46858088
MYL3not specifiedLikely benign
(May 24, 2016)
criteria provided, single submitter
8.
GRCh37:
Chr3:46899681
GRCh38:
Chr3:46858191
MYL3not providedBenign
(Mar 3, 2015)
criteria provided, single submitter
9.
GRCh37:
Chr3:46899716
GRCh38:
Chr3:46858226
MYL3not specified, Hypertrophic cardiomyopathy 8, Cardiomyopathy
Likely benign
(Aug 28, 2019)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr3:46899721
GRCh38:
Chr3:46858231
MYL3Hypertrophic cardiomyopathy 8Uncertain significance
(Aug 20, 2021)
criteria provided, single submitter
11.
GRCh37:
Chr3:46899725
GRCh38:
Chr3:46858235
MYL3not specifiedBenign
(May 27, 2015)
criteria provided, single submitter
12.
GRCh37:
Chr3:46899728
GRCh38:
Chr3:46858238
MYL3CardiomyopathyUncertain significance
(Jun 1, 2019)
criteria provided, single submitter
13.
GRCh37:
Chr3:46899729
GRCh38:
Chr3:46858239
MYL3not specified, Cardiomyopathy, Hypertrophic cardiomyopathy 8
Conflicting interpretations of pathogenicity
(Nov 20, 2019)
criteria provided, conflicting interpretations
14.
GRCh37:
Chr3:46899731
GRCh38:
Chr3:46858241
MYL3CardiomyopathyBenign
(Jan 28, 2020)
criteria provided, single submitter
15.
GRCh37:
Chr3:46899740
GRCh38:
Chr3:46858250
MYL3CardiomyopathyLikely benign
(Mar 9, 2020)
criteria provided, single submitter
16.
GRCh37:
Chr3:46899743
GRCh38:
Chr3:46858253
MYL3M193fsHypertrophic cardiomyopathyUncertain significance
(Mar 1, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr3:46899743
GRCh38:
Chr3:46858253
MYL3M193IHypertrophic cardiomyopathyUncertain significance
(Aug 28, 2021)
criteria provided, single submitter
18.
GRCh37:
Chr3:46899745
GRCh38:
Chr3:46858255
MYL3M193VCardiomyopathyUncertain significance
(Feb 11, 2019)
criteria provided, single submitter
19.
GRCh37:
Chr3:46899746-46899747
GRCh38:
Chr3:46858256-46858257
MYL3M193fsCardiovascular phenotype, Hypertrophic cardiomyopathyUncertain significance
(Feb 26, 2021)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr3:46899747
GRCh38:
Chr3:46858257
MYL3I129N, I134N, I192NHypertrophic cardiomyopathyUncertain significance
(Mar 3, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr3:46899751
GRCh38:
Chr3:46858261
MYL3H191DPrimary familial hypertrophic cardiomyopathyUncertain significance
(Sep 1, 2015)
criteria provided, single submitter
22.
GRCh37:
Chr3:46899754
GRCh38:
Chr3:46858264
MYL3K190EHypertrophic cardiomyopathy, not providedUncertain significance
(Sep 26, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr3:46899755
GRCh38:
Chr3:46858265
MYL3CardiomyopathyLikely benign
(Dec 2, 2019)
criteria provided, single submitter
24.
GRCh37:
Chr3:46899763
GRCh38:
Chr3:46858273
MYL3Hypertrophic cardiomyopathyUncertain significance
(Oct 14, 2021)
criteria provided, single submitter
25.
GRCh37:
Chr3:46899763
GRCh38:
Chr3:46858273
MYL3CardiomyopathyUncertain significance
(May 15, 2019)
criteria provided, single submitter
26.
GRCh37:
Chr3:46899764
GRCh38:
Chr3:46858274
MYL3Hypertrophic cardiomyopathyUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
27.
GRCh37:
Chr3:46899765
GRCh38:
Chr3:46858275
MYL3Primary familial hypertrophic cardiomyopathyUncertain significance
(Jan 26, 2015)
criteria provided, single submitter
28.
GRCh37:
Chr3:46899769
GRCh38:
Chr3:46858279
MYL3Hypertrophic cardiomyopathyLikely benign
(May 1, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr3:46899772
GRCh38:
Chr3:46858282
MYL3Hypertrophic cardiomyopathyLikely benign
(Jul 24, 2019)
criteria provided, single submitter
30.
GRCh37:
Chr3:46899776-46899777
GRCh38:
Chr3:46858286-46858287
MYL3CardiomyopathyLikely benign
(Oct 16, 2018)
criteria provided, single submitter
31.
GRCh37:
Chr3:46899777
GRCh38:
Chr3:46858287
MYL3Hypertrophic cardiomyopathyLikely benign
(Jul 29, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr3:46899777
GRCh38:
Chr3:46858287
MYL3Hypertrophic cardiomyopathy, CardiomyopathyConflicting interpretations of pathogenicity
(Jul 17, 2022)
criteria provided, conflicting interpretations
33.
GRCh37:
Chr3:46899792
GRCh38:
Chr3:46858302
MYL3not providedBenign
(Mar 3, 2015)
criteria provided, single submitter
34.
GRCh37:
Chr3:46899843-46899858
GRCh38:
Chr3:46858353-46858368
MYL3Hypertrophic cardiomyopathyLikely benign
(Aug 22, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr3:46899855
GRCh38:
Chr3:46858365
MYL3not specified, Hypertrophic cardiomyopathyBenign
(Sep 24, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr3:46899868
GRCh38:
Chr3:46858378
MYL3not specified, Cardiomyopathy, Hypertrophic cardiomyopathy
Benign/Likely benign
(Oct 23, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr3:46899872
GRCh38:
Chr3:46858382
MYL3Hypertrophic cardiomyopathyUncertain significance
(Jul 16, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr3:46899876
GRCh38:
Chr3:46858386
MYL3E186AHypertrophic cardiomyopathy 8, not provided, Cardiomyopathy
Uncertain significance
(Feb 1, 2023)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr3:46899878
GRCh38:
Chr3:46858388
MYL3CardiomyopathyLikely benign
(Feb 18, 2021)
criteria provided, single submitter
40.
GRCh37:
Chr3:46899880
GRCh38:
Chr3:46858390
MYL3Y185NHypertrophic cardiomyopathyUncertain significance
(Aug 9, 2021)
criteria provided, single submitter
41.
GRCh37:
Chr3:46899881
GRCh38:
Chr3:46858391
MYL3Cardiovascular phenotype, Hypertrophic cardiomyopathy, Cardiomyopathy
Likely benign
(Nov 18, 2021)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr3:46899884
GRCh38:
Chr3:46858394
MYL3Cardiomyopathy, Hypertrophic cardiomyopathy, Cardiovascular phenotype,
not specified
Likely benign
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr3:46899887
GRCh38:
Chr3:46858397
MYL3CardiomyopathyLikely benign
(Nov 12, 2019)
criteria provided, single submitter
44.
GRCh37:
Chr3:46899894
GRCh38:
Chr3:46858404
MYL3N180SHypertrophic cardiomyopathy, CardiomyopathyUncertain significance
(Sep 10, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr3:46899897
GRCh38:
Chr3:46858407
MYL3S179FHypertrophic cardiomyopathyUncertain significance
(Oct 13, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr3:46899897
GRCh38:
Chr3:46858407
MYL3S179YHypertrophic cardiomyopathyUncertain significance
(Aug 20, 2021)
criteria provided, single submitter
47.
GRCh37:
Chr3:46899901
GRCh38:
Chr3:46858411
MYL3D178NCardiovascular phenotype, not provided, not specified,
Cardiomyopathy, Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Dec 27, 2022)
criteria provided, conflicting interpretations
48.
GRCh37:
Chr3:46899903
GRCh38:
Chr3:46858413
MYL3E177GCardiovascular phenotype, not specified, not provided,
Cardiomyopathy, Hypertrophic cardiomyopathy 8, Hypertrophic cardiomyopathy
Uncertain significance
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr3:46899912
GRCh38:
Chr3:46858422
MYL3A174VCardiomyopathyUncertain significance
(Oct 4, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr3:46899913
GRCh38:
Chr3:46858423
MYL3A174Pnot specified, CardiomyopathyUncertain significance
(Nov 9, 2017)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr3:46899915
GRCh38:
Chr3:46858425
MYL3M173Tnot provided, Hypertrophic cardiomyopathy, Cardiovascular phenotype
Uncertain significance
(Nov 25, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr3:46899915
GRCh38:
Chr3:46858425
MYL3M173KHypertrophic cardiomyopathy, not providedConflicting interpretations of pathogenicity
(Mar 23, 2022)
criteria provided, conflicting interpretations
53.
GRCh37:
Chr3:46899916
GRCh38:
Chr3:46858426
MYL3M173VCardiomyopathy, not specified, not provided,
Hypertrophic cardiomyopathy 8, Hypertrophic cardiomyopathy
Uncertain significance
(Sep 13, 2022)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr3:46899917
GRCh38:
Chr3:46858427
MYL3Cardiovascular phenotype, not specified, Cardiomyopathy,
Hypertrophic cardiomyopathy
Likely benign
(May 27, 2022)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr3:46899919
GRCh38:
Chr3:46858429
MYL3Cardiomyopathy, Hypertrophic cardiomyopathyLikely benign
(Sep 23, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr3:46899925
GRCh38:
Chr3:46858435
MYL3E170QHypertrophic cardiomyopathy, Cardiovascular phenotypeUncertain significance
(Sep 5, 2022)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr3:46899925
GRCh38:
Chr3:46858435
MYL3E170KHypertrophic cardiomyopathyUncertain significance
(Feb 28, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr3:46899926
GRCh38:
Chr3:46858436
MYL3Hypertrophic cardiomyopathy 8, Hypertrophic cardiomyopathyLikely benign
(Sep 17, 2021)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr3:46899928
GRCh38:
Chr3:46858438
MYL3V106M, V169M, V111MHypertrophic cardiomyopathyUncertain significance
(Apr 16, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr3:46899928
GRCh38:
Chr3:46858438
MYL3V111L, V106L, V169LHypertrophic cardiomyopathyUncertain significance
(Aug 22, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr3:46899929
GRCh38:
Chr3:46858439
MYL3Hypertrophic cardiomyopathyLikely benign
(May 16, 2018)
criteria provided, single submitter
62.
GRCh37:
Chr3:46899930
GRCh38:
Chr3:46858440
MYL3E110A, E168A, E105AHypertrophic cardiomyopathyUncertain significance
(Mar 5, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr3:46899931
GRCh38:
Chr3:46858441
MYL3E168KCardiomyopathyUncertain significance
(Dec 7, 2018)
criteria provided, single submitter
64.
GRCh37:
Chr3:46899932
GRCh38:
Chr3:46858442
MYL3not specified, Cardiomyopathy, Hypertrophic cardiomyopathy
Likely benign
(May 14, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr3:46899934
GRCh38:
Chr3:46858444
MYL3D167NCardiovascular phenotype, CardiomyopathyUncertain significance
(Mar 10, 2021)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr3:46899939
GRCh38:
Chr3:46858449
MYL3T165RHypertrophic cardiomyopathyUncertain significance
(Mar 1, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr3:46899945
GRCh38:
Chr3:46858455
MYL3R163KCardiomyopathyUncertain significance
(Mar 7, 2019)
criteria provided, single submitter
68.
GRCh37:
Chr3:46899946
GRCh38:
Chr3:46858456
MYL3R163GCardiovascular phenotype, Hypertrophic cardiomyopathyUncertain significance
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr3:46899947
GRCh38:
Chr3:46858457
MYL3E104D, E162DHypertrophic cardiomyopathyUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr3:46899949
GRCh38:
Chr3:46858459
MYL3E162KCardiomyopathyUncertain significance
(Oct 25, 2018)
criteria provided, single submitter
71.
GRCh37:
Chr3:46899950
GRCh38:
Chr3:46858460
MYL3Hypertrophic cardiomyopathy, CardiomyopathyLikely benign
(Aug 18, 2020)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr3:46899951
GRCh38:
Chr3:46858461
MYL3G161Dnot specifiedUncertain significance
(Nov 11, 2016)
criteria provided, single submitter
73.
GRCh37:
Chr3:46899952
GRCh38:
Chr3:46858462
MYL3not specifiedUncertain significance
(Oct 15, 2013)
criteria provided, single submitter
74.
GRCh37:
Chr3:46899953
GRCh38:
Chr3:46858463
MYL3not providednot providedno assertion provided
75.
GRCh37:
Chr3:46899957
GRCh38:
Chr3:46858467
MYL3Primary familial hypertrophic cardiomyopathyUncertain significance
(Nov 25, 2014)
no assertion criteria provided
76.
GRCh37:
Chr3:46899960
GRCh38:
Chr3:46858470
MYL3CardiomyopathyUncertain significance
(Oct 2, 2018)
criteria provided, single submitter
77.
GRCh37:
Chr3:46899961
GRCh38:
Chr3:46858471
MYL3not providedLikely pathogenicno assertion criteria provided
78.
GRCh37:
Chr3:46899965
GRCh38:
Chr3:46858475
MYL3not specified, not provided, Cardiomyopathy,
Hypertrophic cardiomyopathy
Benign/Likely benign
(Oct 23, 2022)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr3:46899968
GRCh38:
Chr3:46858478
MYL3not specified, Hypertrophic cardiomyopathyBenign/Likely benign
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr3:46899969
GRCh38:
Chr3:46858479
MYL3not providedLikely benignno assertion criteria provided
81.
GRCh37:
Chr3:46899971
GRCh38:
Chr3:46858481
MYL3Hypertrophic cardiomyopathyLikely benign
(Aug 1, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr3:46900051
GRCh38:
Chr3:46858561
MYL3not providedBenign
(Mar 3, 2015)
criteria provided, single submitter
83.
GRCh37:
Chr3:46900950
GRCh38:
Chr3:46859460
MYL3Hypertrophic cardiomyopathyLikely benign
(Aug 29, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr3:46900955
GRCh38:
Chr3:46859465
MYL3Hypertrophic cardiomyopathyLikely benign
(Nov 14, 2018)
criteria provided, single submitter
85.
GRCh37:
Chr3:46900960
GRCh38:
Chr3:46859470
MYL3Cardiovascular phenotype, Hypertrophic cardiomyopathyUncertain significance
(Sep 6, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr3:46900965
GRCh38:
Chr3:46859475
MYL3G103S, E103K, G161SHypertrophic cardiomyopathyUncertain significance
(Jan 19, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr3:46900965
GRCh38:
Chr3:46859475
MYL3G161CHypertrophic cardiomyopathy 8Uncertain significance
(Mar 29, 2018)
criteria provided, single submitter
88.
GRCh37:
Chr3:46900969
GRCh38:
Chr3:46859479
MYL3Cardiomyopathy, Hypertrophic cardiomyopathy, not provided,
Cardiovascular phenotype
Likely benign
(Jul 13, 2022)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr3:46900969
GRCh38:
Chr3:46859479
MYL3not specified, Cardiomyopathy, Cardiovascular phenotype,
Hypertrophic cardiomyopathy
Benign/Likely benign
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr3:46900970
GRCh38:
Chr3:46859480
MYL3T159MCardiovascular phenotype, Hypertrophic cardiomyopathy, Cardiomyopathy
Uncertain significance
(Sep 25, 2022)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr3:46900971
GRCh38:
Chr3:46859481
MYL3T101S, T159SCardiovascular phenotypeUncertain significance
(Aug 28, 2018)
criteria provided, single submitter
92.
GRCh37:
Chr3:46900980
GRCh38:
Chr3:46859490
MYL3V156LHypertrophic cardiomyopathy, Restrictive cardiomyopathy, Hypertrophic cardiomyopathy
Uncertain significance
(Aug 26, 2021)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr3:46900980
GRCh38:
Chr3:46859490
MYL3V156Lnot specified, not provided, Cardiomyopathy,
Hypertrophic cardiomyopathy 8, Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Oct 1, 2022)
criteria provided, conflicting interpretations
94.
GRCh37:
Chr3:46900980
GRCh38:
Chr3:46859490
MYL3V156MCardiovascular phenotype, not specified, not provided,
Cardiomyopathy, Hypertrophic cardiomyopathy 8, Primary familial hypertrophic cardiomyopathy,
Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Aug 28, 2023)
criteria provided, conflicting interpretations
95.
GRCh37:
Chr3:46900981
GRCh38:
Chr3:46859491
MYL3not specified, Cardiomyopathy, Cardiovascular phenotype,
Hypertrophic cardiomyopathy
Likely benign
(Jul 12, 2022)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr3:46900982
GRCh38:
Chr3:46859492
MYL3H97L, H155LHypertrophic cardiomyopathyUncertain significance
(Dec 17, 2021)
criteria provided, single submitter
97.
GRCh37:
Chr3:46900983
GRCh38:
Chr3:46859493
MYL3H155Dnot provided, Hypertrophic cardiomyopathyConflicting interpretations of pathogenicity
(May 5, 2022)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr3:46900985
GRCh38:
Chr3:46859495
MYL3R154HCardiovascular phenotype, not specified, not provided,
Cardiomyopathy, Hypertrophic cardiomyopathy 8, Hypertrophic cardiomyopathy
Uncertain significance
(Oct 26, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr3:46900986
GRCh38:
Chr3:46859496
MYL3R154CCardiovascular phenotype, not specified, Cardiomyopathy,
Hypertrophic cardiomyopathy
Uncertain significance
(Oct 3, 2022)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr3:46900988-46900992
GRCh38:
Chr3:46859498-46859502
MYL3Hypertrophic cardiomyopathyUncertain significance
(May 14, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination